Clinic-pathological variables were compared between patients with and without TERT promoter mutations in their tumors, and there were no differences in age, sex, HBV infection, liver cirrhosis, α-fetoprotein levels, tumor sizes, differentiation status and metastasis (Table 1). This evidence concerns the gene TERT and neoplasm.